Biotech stocks are surging. How investors can play the new drug innovation boom

by admin 0 Comments

Investing
Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

Read the original report.

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

Articles You May Like

If Elon Musk gifts SpaceX stock through Trump Accounts, it will come with a catch
Procter & Gamble earnings beat as sales rise 4%, boosted by laundry and home products
Moderna shares plunge after cancer vaccine data leaks — despite positive results
Netflix posts third-quarter earnings beat, but shares fall on advertising and revenue guidance
One telco carried 98% of the scam calls Vodafone saw in a year, and the blame game has begun

Leave a Reply

Your email address will not be published. Required fields are marked *